Panbela Therapeutics (PBLA) Expected to Release Earnings on Friday

Panbela Therapeutics (OTCMKTS:PBLA – Get Free Report) is expected to issue its resultson Friday, November 13th. Analysts expect the company to post earnings of ($2,640.00) per share for the quarter.

Panbela Therapeutics Price Performance

Shares of Panbela Therapeutics stock opened at $0.01 on Friday. Panbela Therapeutics has a 12-month low of $0.00 and a 12-month high of $0.10. The company’s 50-day moving average price is $0.01 and its 200-day moving average price is $0.01.

About Panbela Therapeutics

(Get Free Report)

Panbela Therapeutics, Inc is a biotechnology company focused on developing novel therapies for cancer and other serious diseases. The company’s research has centered on treatments that target polyamine metabolism, a biological process associated with tumor growth and cancer progression.

Panbela’s lead investigational product has been ivospemin, formerly known as SBP-101, which has been studied in combination with standard treatments for pancreatic ductal adenocarcinoma and other solid tumors.

See Also

Earnings History for Panbela Therapeutics (OTCMKTS:PBLA)

Receive News & Ratings for Panbela Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Panbela Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.